Cranial Irradiation is Essential in the Treatment of Childhood Acute Myelogenous Leukemia: Results of Study AML-BFM-87

  • U. Creutzig
  • J. Ritter
  • G. Schellong
  • AML-BFM Study Group
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 36)


In children with acute myelogenous leukemia (AML) the value of prophylactic cranial irradiation still remains controversial. In the first two German pediatric AML studies BFM-78 and -83 [1,2] cranial irradiation was included, whereas in study AML-BFM-87 patients were initially randomized for irradiation to determine the therapeutic value of irradiation for preventing CNS relapses. Later in study AML-BFM-87 CNS irradiation was abandoned in patients without CNS involvement to reduce CNS toxicity. However, first analyses suggest cranial irradiation should be included in the therapy of all patients with AML, not only to prevent CNS- but also systemic relapses.


Acute Myelogenous Leukemia Cranial Irradiation Acute Myelogenous Leukemia Patient Continuous Complete Remission Central Nervous System Leukemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Creutzig U, Ritter J, Riehm H, Langermann H-J, Henze G, Kabisch H, Niethammer D, Jürgens H, Stollmann B, Lasson U, Kaufmann U, Löffler H, Schellong G (1985) Improved treatment results in childhood acute myelogenous leukemia: A report of the German Cooperative Study AMLBFM- 78. Blood 65: 298–304PubMedGoogle Scholar
  2. 2.
    Creutzig U, Ritter J, Schellong G (1990) Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood 75: 1932–1940PubMedGoogle Scholar
  3. 3.
    Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1976) Proposals for the classification of the acute leukaemias. Br J Haematol 33: 451–458PubMedCrossRefGoogle Scholar
  4. 4.
    Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Inn Med 103: 626–629Google Scholar
  5. 5.
    Creutzig U, Ritter J, Schellong G for the German AML-BFM Study Group (1992) Involvement of the CNS in childhood AML. Experiences of the AML-BFM-Studies -78,-83, and 87. In: Hiddemann W, Büchner T, Keating M, Plunkett W, Wörmann B, Andreeff M (eds) Acute Leukemias. Springer Verlag, Berlin, Heidelberg, New York, pp 491–496 (Pharmacokinetics and Management of Relapsed and Refractory Disease, vol 34)Google Scholar
  6. 6.
    Pui Ch, Dahl GV, Kalwinsky DK, Look ATh, Mirro J, Dodge RK, Simone JV (1985) Central nervous system leukemia in children with acute nonlymphoblastic leukemia. Blood 65: 1062–1067Google Scholar
  7. 7.
    Riehm H, Gadner H, Henze G, Kornhuber B, Langermann H-J, Müller-Weihrich St, Schellong G (1983) Acute lymphoblastic leukemia: treatment results in three BFM studies (1970–1981) In: Murphy SB, Gilbert JR (eds), Leukemia Research: advances in cell biology and treatment. Elsevier, Amsterdam, pp 251–263Google Scholar
  8. 8.
    Pinkel D, Simone J, Hustu HO, Aur RJA (1972) Nine year’s experience with “total therapy” of childhood acute lymphocytic leukemia. Pediatrics 50: 246–251PubMedGoogle Scholar
  9. 9.
    Schrappe M, Beck M, Brandeis WE, Feickert HJ, Gadner H, Graf H, Havers W, Henze G, Jobke A, Kornhuber B, Kühl J, Lampert F, Müller-Weihrich St, Niethammer D, Reiter A, Rister M, Ritter J, Schellong G, Tausch W, Weinel P, Riehm H (1987) Die Behandlung der akuten lymphoblastischen Leukämie im Kindes- und Jugendalter: Ergebnisse der multizentrischen Therapiestudie ALL-BFM-8I. Klin Pädiatr 199: 133–150PubMedCrossRefGoogle Scholar
  10. 10.
    Henze G, Fengler R, Hartmann R, Kornhuber B, Janka-Schaub G, Niethammer D, Riehm H (1991) Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group. Blood 78: 1166–1172PubMedGoogle Scholar
  11. 11.
    Dahl GV, Simone JV, Hustu HO, Mason C(1978) Preventive central nervous system irradiation in children with acute nonlymphocytic leukemia. Cancer 42: 2187–2192PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • U. Creutzig
    • 1
  • J. Ritter
    • 1
  • G. Schellong
    • 1
  • AML-BFM Study Group
    • 1
  1. 1.University Children’s Hospital MünsterGermany

Personalised recommendations